These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 455336)

  • 1. Anthracycline analogs: re-assessments and prospects.
    Carter SK
    Cancer Treat Rep; 1979 May; 63(5):935-6. PubMed ID: 455336
    [No Abstract]   [Full Text] [Related]  

  • 2. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study of aclacinomycin A.
    Ogawa M; Inagaki J; Horikoshi N; Inoue K; Chinen T; Ueoka H; Nagura E
    Cancer Treat Rep; 1979 May; 63(5):931-4. PubMed ID: 455335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline derivatives in new drug development programs.
    Rozencweig M; De Sloover C; Von Hoff DD; Tagnon HJ; Muggia FM
    Cancer Treat Rep; 1979 May; 63(5):807-8. PubMed ID: 455322
    [No Abstract]   [Full Text] [Related]  

  • 6. Adriamycin (NSC-123127) in the treatment of acute myelocytic leukemia.
    Cortex EP; Ellison RR; Yates JW
    Cancer Chemother Rep; 1972 Apr; 56(2):237-43. PubMed ID: 4504970
    [No Abstract]   [Full Text] [Related]  

  • 7. Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children.
    Lewis AB; Crouse VL; Evans W; Takahashi M; Siegel SE
    Pediatrics; 1981 Jul; 68(1):67-72. PubMed ID: 6941210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future clinical investigations with anthracycline antibiotics in relation to daunorubicin.
    Muggia FM; Blum RH; Wernz JC
    Cancer Treat Rep; 1981; 65 Suppl 4():35-7. PubMed ID: 6955012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents.
    Schwartz HS; Kanter PM
    Cancer Treat Rep; 1979 May; 63(5):821-5. PubMed ID: 287555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anthracycline cardiotoxicity: review].
    Ribera JM; Montserrat E; Rozman C
    Sangre (Barc); 1983; 28(1):54-68. PubMed ID: 6346540
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I study of pirarubicin.
    Miller AA; Scheulen ME; Kleeberg UR; Seeber S; Schmidt CG
    J Cancer Res Clin Oncol; 1988; 114(1):91-4. PubMed ID: 3162456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rodorubicin, a new tetraglycosidic anthracycline.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1988 Apr; (82):216-30. PubMed ID: 3165634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
    Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
    Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
    Gockerman JP; Raney M; Logan T
    Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1980; 74():207-16. PubMed ID: 7003659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycin.
    Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Mechl Z; Nekulova M; Kolariĉ K; Tomek R; Röthig J
    Eur J Haematol Suppl; 1987; 47():67-9. PubMed ID: 3471527
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
    Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
    [No Abstract]   [Full Text] [Related]  

  • 19. New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.
    Cassinelli G; Ballabio M; Arcamone F; Casazza AM; Podesta' A
    J Antibiot (Tokyo); 1985 Jul; 38(7):856-67. PubMed ID: 3861603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.